Medical Management of the Liver Transplant Recipient

摘要: Long-term survival of liver transplant recipients has become the rule rather than exception. As a result, medical complications long-term survival, including atherosclerotic cardiovascular disease, metabolic bone and de novo malignancy, have accounted for an increasing proportion late morbidity mortality. Risk factors these begin before are potentially modifiable but exacerbated by requirement immunosuppressive medications after transplantation. Surveillance early intervention programs administered hepatologists other subspecialists may improve outcomes in ameliorating risk atherosclerosis, fractures, cancer.